Squarepoint
TMCI icon

Squarepoint’s Treace Medical Concepts TMCI Stock Holding History

Squarepoint’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-28,988
Closed -$195K – 4893
2025
Q3 		$195K Sell
28,988
-19,984
-41% -$130K ﹤0.01% 3958
2025
Q2 		$288K Buy
+48,972
New +$319K ﹤0.01% 3725
2025
Q1 		– Sell
-18,470
Closed -$137K – 5414
2024
Q4 		$137K Sell
18,470
-52,890
-74% -$354K ﹤0.01% 4607
2024
Q3 		$414K Sell
71,360
-46,687
-40% -$300K ﹤0.01% 3241
2024
Q2 		$785K Buy
118,047
+88,577
+301% +$716K ﹤0.01% 2738
2024
Q1 		$385K Sell
29,470
-100,800
-77% -$1.34M ﹤0.01% 3224
2023
Q4 		$1.66M Buy
130,270
+13,476
+12% +$136K ﹤0.01% 2141
2023
Q3 		$1.53M Buy
116,794
+99,359
+570% +$1.82M ﹤0.01% 2020
2023
Q2 		$446K Sell
17,435
-46,399
-73% -$1.2M ﹤0.01% 2690
2023
Q1 		$1.61M Buy
63,834
+13,679
+27% +$321K 0.01% 1566
2022
Q4 		$1.15M Buy
+50,155
New +$1.15M ﹤0.01% 1729

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Squarepoint's TMCI Position: Q4 2025 in Review

Squarepoint sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 28,988 shares — an estimated $195K sold.

Squarepoint first reported a position in TMCI in Q4 2022 and held it in 11 quarters. The position peaked at $1.66M in Q4 2023. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Squarepoint reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 28,988 Treace Medical Concepts shares in Q4 2025, an estimated $195K.
  • Squarepoint first reported a position in Treace Medical Concepts in Q4 2022 and held it in 11 quarters.
  • Squarepoint's Treace Medical Concepts position peaked at $1.66M in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.